Bahl & Gaynor’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $201K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $202K | Sell |
|
|||||
|
2024
Q1 | $207K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $207K | Buy |
|
|||||
|
2022
Q4 | $227K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $342K | Hold |
|
|||||
|
2021
Q3 | $275K | Hold |
|
|||||
|
2021
Q2 | $281K | Hold |
|
|||||
|
2021
Q1 | $265K | Hold |
|
|||||
|
2020
Q4 | $237K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $213K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $203K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $294K | Hold |
|
|||||
|
2017
Q3 | $248K | Hold |
|
|||||
|
2017
Q2 | $246K | Hold |
|
|||||
|
2017
Q1 | $216K | Sell |
|
|||||
|
2016
Q4 | $209K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $247K | Hold |
|
|||||
|
2015
Q4 | $248K | Sell |
|
|||||
|
2015
Q3 | $253K | Buy |
|
|||||
|
2015
Q2 | $292K | Buy |
|